Gut Microbiome and Premenstrual Syndrome (PMS)

Premenstrual syndrome, known as PMS, is one of the most common yet underestimated conditions affecting women’s daily lives. It is estimated that up to 70 to 80% of women of reproductive age experience some form of symptoms before menstruation, such as irritability, fatigue, bloating, headaches, or sleep disturbances. In a smaller but significant percentage, symptoms are severe enough to impact quality of life and professional functioning.

Traditionally, PMS has been attributed exclusively to hormonal fluctuations during the menstrual cycle, mainly changes in estrogen and progesterone. However, modern research shows that the picture is more complex. The intensity of symptoms does not depend only on hormone levels, but also on how the body metabolizes and responds to them.

At this point, the gut microbiome, meaning the collection of microorganisms living in the intestine, becomes particularly important. The microbiome is not just a passive “resident” but an active regulator of many body systems, including the immune, nervous, and hormonal axes.

In recent years, increasing evidence suggests that the composition and function of the gut microbiome may influence PMS symptoms. Understanding this relationship opens new pathways for both prevention and personalized management.

The biology behind the connection between microbiome and PMS

To understand the relationship between the gut microbiome and PMS, we need to examine how intestinal bacteria interact with hormones.

A key term used in modern literature is the “estrobolome.” This refers to the collection of gut bacteria involved in estrogen metabolism. These bacteria produce enzymes such as beta-glucuronidase, which influence the reabsorption of estrogens in the body.

Thus, when the microbiome is balanced:

It contributes to the proper elimination of excess estrogens
It supports hormonal balance
It reduces the likelihood of inflammation

In contrast, in a state of dysbiosis, meaning disruption of microbial balance:

Estrogen recirculation increases
The ratio of estrogen to progesterone is disturbed
Low-grade inflammation is enhanced

These changes are directly associated with PMS symptoms such as breast tenderness, fluid retention, and emotional instability.

In addition, the microbiome plays a prominent role through the gut-brain axis, particularly by producing neurotransmitters such as serotonin, as well as through immune mechanisms, which can affect mood and pain perception. It is noteworthy that approximately 90% of serotonin is produced in the gut. Modern studies show that women with severe premenstrual symptoms exhibit differences in microbiome composition compared to asymptomatic women, supporting the hypothesis of a causal relationship.

Functional medicine: from symptoms to mechanisms

Functional medicine does not focus only on “what” the patient experiences, but mainly on “why.” In the case of PMS, this means we do not limit ourselves to recording symptoms; instead, we investigate the underlying mechanisms.

The gut microbiome is one of the key pillars of this approach. Dysbiosis may result from many factors, such as a low-fiber diet, excessive sugar consumption, chronic stress, antibiotic use, or lack of sleep. Within this framework, functional medicine evaluates:

The balance of microorganisms in the gut: Microbiome analysis can reveal reduced diversity or overgrowth of specific bacteria associated with inflammation or disrupted hormone metabolism.
Inflammatory markers: Low-grade inflammation has been linked to increased severity of PMS symptoms. Markers such as CRP and IL-6 can provide valuable insights.
The absorption of micronutrients: Deficiencies in magnesium, B vitamins, or vitamin D may worsen symptoms.
The function of the gut-brain axis: The connection between microbiome and mental health is critical, especially for symptoms such as anxiety and irritability.

At Diagnostiki Athinon, specialized tests that can help map these mechanisms are:

CycloScan® Menstrual Cycle Assessment: Evaluates key menstrual cycle hormones (estradiol, progesterone, testosterone, and DHEA-S) through multiple salivary measurements. Helps identify hormonal fluctuations associated with PMS symptoms and may be correlated with gut microbiome and estrobolome findings.
EnteroScan®: A modern molecular analysis of the gut microbiome assessing biodiversity, SCFA production, and markers of inflammation or increased intestinal permeability. Dysbiosis may influence estrogen metabolism and contribute to PMS-related symptoms such as bloating, fatigue, and mood fluctuations.
FemoScan® Vaginal Microbiome Assessment: Evaluates vaginal microbial balance, which is influenced by hormonal fluctuations and may be associated with inflammation and PMS-related symptoms.
Chronic Inflammation Panel (ImmuneScan®): Includes low-grade chronic inflammation markers associated with metabolic and immune processes that may influence PMS symptom severity.
NutriScan® Vitamin Profile & NeuroScan® Neurotransmitter Profile: Their combination detects potential vitamin deficiencies involved in neurotransmitter synthesis, while also assessing key neurotransmitters such as serotonin and GABA, which are linked to mood, sleep, and the gut–brain axis.

The value of this approach lies in personalization. Two women with similar PMS symptoms may have completely different underlying causes. In one, the primary issue may be dysbiosis, while in another it may be inflammation or micronutrient deficiency.

Nutrition and lifestyle: practical interventions

Improving the gut microbiome does not necessarily require complex interventions. Small but targeted changes in diet and lifestyle can have a significant impact. Some key directions include:

Increasing fiber intake: Dietary fiber serves as “fuel” for beneficial bacteria. Consuming vegetables, fruits, legumes, and whole grains helps increase microbial diversity. This is associated with better estrogen regulation and reduced inflammation.
Consuming probiotics and fermented foods: Foods such as yogurt, kefir, and sauerkraut can support microbiome composition. Some studies suggest that specific Lactobacillus strains may reduce PMS symptoms.
Reducing processed foods and sugar: Excess consumption of sugar and ultra-processed foods is associated with dysbiosis and increased inflammation, which may worsen symptoms.
Adequate intake of magnesium and B vitamins: Magnesium supports nervous system relaxation and may reduce cramps and irritability. B vitamins support neurotransmitter synthesis.
Stress management: Chronic stress negatively affects both the microbiome and the gut-brain axis. Techniques such as exercise, breathing practices, and sufficient sleep have proven benefits.
Consistent sleep: The circadian rhythm influences both hormones and the microbiome. Good-quality sleep is a key factor in maintaining balance.

It is important to emphasize that there is no single “PMS diet” that works for everyone. Personalization, based on laboratory data and clinical presentation, is essential.

Conclusion and next steps

The relationship between the gut microbiome and premenstrual syndrome is one of the most interesting areas of modern medicine. It is not merely a theoretical link, but a practical pathway toward better understanding and managing symptoms.

Functional medicine provides the tools to move from a general approach to a more targeted and personalized strategy. Through appropriate testing and lifestyle interventions, we can positively influence both the microbiome and hormonal balance.

If you experience PMS symptoms or wish to take a preventive approach to your health, investigating the gut microbiome may be an important first step.

What You Can Do Today

Discover what is really happening in your body with an EnteroScan®, a specialized functional microbiome analysis that reveals essential insights into your gut and immune balance.
See how Functional Medicine can help in practice - by identifying the root causes of symptoms, rather than simply masking them.
Subscribe to our newsletter to be the first to receive updates on new preventive tests, wellness articles, and practical guidance from Diagnostiki Athinon.

References

Nabeh OA. New insights on the impact of gut microbiota on premenstrual disorders. Will probiotics solve this mystery? Life Sci. 2023 May 15;321:121606. doi: 10.1016/j.lfs.2023.121606. Epub 2023 Mar 21. PMID: 36948390.
Dubois N, Vincent C, Giroux I. Efficacy of Gut Microbiome-Targeted Interventions on Mental Health Symptoms in Women Across Key Hormonal Life Stages: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Healthcare (Basel). 2025 Nov 10;13(22):2851. doi: 10.3390/healthcare13222851. PMID: 41302239; PMCID: PMC12652156.
Kim H, Gwon H, Jeong JW, Kim JY, Shim JJ, Lee JH. A Mechanistic Study of Lactobacillus helveticus HY7801 and Its Extracellular Vesicles in Premenstrual Syndrome: Role of Gut Microbiota and Hormonal Modulation. J Microbiol Biotechnol. 2025 Sep 11;35:e2507014. doi: 10.4014/jmb.2507.07014. PMID: 40935392; PMCID: PMC12438957.
Cao W, Fu X, Zhou J, Qi Q, Ye F, Li L, Wang L. The effect of the female genital tract and gut microbiome on reproductive dysfunction. Biosci Trends. 2024 Jan 30;17(6):458-474. doi: 10.5582/bst.2023.01133. Epub 2023 Dec 17. PMID: 38104979.
Saravinovska, K., Santi, D., Prete, A., Sojat, A. S. ( 02 April 2026). The impact of estrogen status on the gut microbiome: a systematic review and meta-analysis
Kour, H., Andola, S. (2024). The crucial link between gut health, mental well-being, and hormonal fluctuations in females. Indian Journal of Health Sciences.
Leao L, Esmail GA, Miri S, Mottawea W, Hammami R. In vitro modeling of the female gut microbiome: effects of sex hormones and psychotropic drugs. Microbiol Spectr. 2025 Dec 2;13(12):e0235025. doi: 10.1128/spectrum.02350-25. Epub 2025 Oct 20. PMID: 41114510; PMCID: PMC12671099.
Rosas-Sánchez GU, Germán-Ponciano LJ, Rodríguez-Landa JF, Bonilla-Jaime H, Limón-Morales O, García-Ríos RI, Muñoz-Carrillo JL, Gutiérrez-Coronado O, Villalobos-Gutiérrez PT, Soria-Fregozo C. Estrogenic Effect of Probiotics on Anxiety and Depression: A Narrative Review. Int J Mol Sci. 2025 Oct 13;26(20):9948. doi: 10.3390/ijms26209948. PMID: 41155243; PMCID: PMC12562881.

At Diagnostiki Athinon, we treat prevention with the seriousness it deserves. This is where science meets personalized care.